Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dean Mitchell

Dean Mitchell is recorded as CFO at Enact Holdings, Inc. (ACT). Dean Mitchell was last confirmed as Board Member at Praxis Precision Medicines, Inc. (PRAX) in a filing dated April 26, 2024. Praxis Precision Medicines, Inc. reported in an 8-K filed June 6, 2024 that Dean Mitchell was appointed Class I Director, effective June 5, 2024. Dean Mitchell has spoken on 20 earnings calls across 1 company, most recently for Enact Holdings, Inc. on August 6, 2026.

“The Company's stockholders elected Dean Mitchell and Jill DeSimone to serve as Class I members of the Board of Directors of the Company (the "Board") until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal, with the votes cast as follows:”
Praxis Precision Medicines, Inc. Form 8-K, filed June 6, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Enact Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 9 earlier activities